Johnson Johnson (JNJ) Shares Declined While Bp Plc Decreased by $7.74 Million Its Stake

Johnson & Johnson (NYSE:JNJ) Corporate LogoBig Money Sentiment decreased to 0.86 in 2018 Q4. It has change of 0.19, from 2018Q3’s 1.05. The ratio dropped due to JNJ positioning: 51 sold and 851 reduced. 145 funds bought stakes and 631 increased stakes. Investors holded 1.70 billion in 2018Q3 but now own 1.79 billion shares or 5.17% more. Twin Capital Mngmt has 215,292 shs. Investec Asset Mngmt Limited holds 5.50 million shs. Arrowstreet Cap Limited Partnership has invested 0.35% in Johnson & Johnson (NYSE:JNJ). Moreover, Thomas J Herzfeld Advisors has 0% invested in Johnson & Johnson (NYSE:JNJ) for 82 shs. Lathrop Investment Mgmt, a Arkansas-based fund reported 4,871 shs. 29,414 were accumulated by Alexandria Cap Ltd Liability. Prio Wealth LP has 263,108 shs. Cornerstone reported 1.77% of its capital in Johnson & Johnson (NYSE:JNJ). Santa Barbara Asset Mngmt Lc reported 963,641 shs or 2% of all its holdings. Brinker Capital invested in 118,997 shs or 0.68% of the stock. Selway Asset holds 13,630 shs. 73,971 were accumulated by Calamos Wealth Ltd Liability Co. Magellan Asset Limited, Australia-based fund reported 681 shs. Cadence Financial Bank Na has 3.23% invested in Johnson & Johnson (NYSE:JNJ) for 55,641 shs. Goldman Sachs Grp Inc Inc invested 0.64% in Johnson & Johnson (NYSE:JNJ).

JNJ registered $74.45 million net activity with 3 buys and 6 sales since November 7, 2018. PEREZ WILLIAM D had bought 1,000 shs worth $133,910. The insider MULCAHY ANNE M bought 748 shs worth $100,050. $268,731 worth of Johnson & Johnson (NYSE:JNJ) was bought by PRINCE CHARLES. On Friday, November 23 a trade for 30,943 shs valued at $4.41 million was made by Sneed Michael E. On Thursday, December 13 $536,638 worth of stock was sold by Kapusta Ronald A. Duato Joaquin sold 40,000 shs worth $5.77 million.

The holdings In Johnson Johnson (JNJ) was decreased owned by Bp Plc. According to 2018Q4 SEC form the reduction is 17.75%. The company’s stock declined 5.44% while stock markets rallied as Bp Plc sold 60,000 shares. The major pharmaceuticals company at the end of 2018Q4 was valued at $35.88M. It’s down from 338,000 at the end of the previous reported quarter. Now it had 278,000 shares held by the hedge fund . $367.52 billion is the market cap of Johnson Johnson. The stock decreased 1.00% or $1.39 during the last trading session, hitting $138.02.Currently Johnson & Johnson is uptrending after 8.80% change in last March 15, 2018. JNJ has also 7.70M shares volume. JNJ outperformed the S&P 500 by 4.43%.

About $2.41 billion US Long portfolio Bp Plc manages. According to a filing the fund rose its stake in Newmont Mining Corp (NYSE:NEM) by 362,000 shares to 428,000 shares, valued at $14.83 million in 2018Q4. Bp Plc has risen its stake in Lamb Weston Holdings Inc and also increased its holding in Cvs Health Corp (NYSE:CVS) by 47,182 shares in the quarter, for a total of 176,182 shares.

On April, 16 WallStreet awaited Johnson & Johnson (NYSE:JNJ)’s earnings report, as reported by RTT. Analysts predict $2.10 EPS. That’s $0.04 up or 1.94 % from 2018’s earnings of $2.06. If the current EPS of $2.10 is accurate, JNJ’s profit could reach $5.59B. Wall Street now predicts 6.60 % EPS growth despite Johnson & Johnson previous quarter’s EPS of $1.97.

For more Johnson & Johnson (NYSE:JNJ) news brought out recently go to: Seekingalpha.com, Investorplace.com, Seekingalpha.com, Seekingalpha.com or Fool.com. The titles are as follows: “Johnson & Johnson receives federal subpoenas – Seeking Alpha” brought out on February 21, 2019, “Is Johnson & Johnson CEO Alex Gorsky Earning His Pay? – Investorplace.com” on February 14, 2019, “Johnson & Johnson: Brace For Impact – Seeking Alpha” with a publish date: March 08, 2019, “FDA OKs J&J’s esketamine nasal spray for depression – Seeking Alpha” and the last “Did Johnson & Johnson Just Spit in Alphabet’s Face? – The Motley Fool” with publication date: February 14, 2019.

Johnson & Johnson (NYSE:JNJ) Ratings Coverage

In total 6 analysts cover Johnson \u0026 Johnson (NYSE:JNJ). “Buy” rating has 4, “Sell” are 0, while 2 are “Hold”. (NYSE:JNJ) has 67% bullish analysts. With $155 highest and $130 lowest target price, Johnson \u0026 Johnson has $147.50 average target price or 6.87% above the current ($138.02) price. 10 are the (NYSE:JNJ)’s ratings reports on Mar 15, 2019 according to StockzIntelligence Inc. On Monday, January 14 the firm has “Outperform” rating by Wells Fargo given. On Thursday, February 14 Credit Suisse maintained Johnson & Johnson (NYSE:JNJ) with “Buy” rating. On Thursday, October 11 the company was maintained by Morgan Stanley. On Monday, October 22 Citigroup maintained Johnson & Johnson (NYSE:JNJ) with “Neutral” rating. In Wednesday, March 6 report Cowen & Co maintained it with “Buy” rating and $155 target. The stock rating was maintained by Morgan Stanley with “Equal-Weight” on Wednesday, January 2. The stock rating was maintained by Citigroup with “Neutral” on Wednesday, January 2. The company rating was maintained by Raymond James on Wednesday, October 17. The stock rating was maintained by Citigroup with “Neutral” on Monday, February 25. On Wednesday, October 17 the rating was maintained by Credit Suisse with “Outperform”.

Johnson & Johnson (NYSE:JNJ) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.